Tuberculosis is associated with expansion of a motile, permissive and immunomodulatory CD16+ monocyte population via the IL-10/STAT3 axis

Cell Research

Volumn 25, Issue 12, 2015, Pages 1333-1351

  Lastrucci, Claire ^a,b   Bénard, Alan ^a,b   Balboa, Luciana ^c   Pingris, Karine ^a,b   Souriant, Shanti ^a,b   Poincloux, Renaud ^a,b   Al Saati, Talal ^d   Rasolofo, Voahangy ^e   González Montaner, Pablo ^f   Inwentarz, Sandra ^f   Moraña, Eduardo Jose ^f   Kondova, Ivanela ^g   Verreck, Frank A W ^g   Del Carmen Sasiain, Maria ^c   Neyrolles, Olivier ^a,b   Maridonneau Parini, Isabelle ^a,b   Lugo Villarino, Geanncarlo ^a,b   Cougoule, Céline ^a,b  

^a INSTITUT DE PHARMACOLOGIE ET DE BIOLOGIE STRUCTURALE   (France)

^b UNIVERSITÉ PAUL SABATIER   (France)

^c ACADEMIA NACIONAL DE MEDICINA   (Argentina)

^d CHU PURPAN   (France)

^e Mycobacteria Unit Pasteur Institute in Antananarivo   (Madagascar)

^f HOSPITAL F J MUÑIZ   (Argentina)

^g BIOMEDICAL PRIMATE RESEARCH CENTRE   (Netherlands)

Author keywords

biomarker; immunomodulation; macrophage activation; migration; monocyte; STAT3; tuberculosis

Indexed keywords

FC RECEPTOR; IL10 PROTEIN, HUMAN; INTERLEUKIN 10; STAT3 PROTEIN; STAT3 PROTEIN, HUMAN;

HUMAN; IMMUNOLOGY; IMMUNOMODULATION; METABOLISM; MONOCYTE; PATHOLOGY; TUBERCULOSIS;

HUMANS; IMMUNOMODULATION; INTERLEUKIN-10; MONOCYTES; RECEPTORS, IGG; STAT3 TRANSCRIPTION FACTOR; TUBERCULOSIS;

EID: 84949099424     PISSN: 10010602     EISSN: 17487838     Source Type: Journal    
DOI: 10.1038/cr.2015.123     Document Type: Article

References (76)

1. Wallis RS, Kim P, Cole S, et al. Tuberculosis biomarkers discovery: developments, needs, and challenges. Lancet Infect Dis 2013; 13: 362-372
2. Kaufmann SH, Parida SK. Tuberculosis in Africa: learning from pathogenesis for biomarker identification. Cell Host Microbe 2008; 4: 219-228
3. Benoit M, Desnues B, Mege JL. Macrophage polarization in bacterial infections. J Immunol 2008; 181: 3733-3739
4. Lugo-Villarino G, Verollet C, Maridonneau-Parini I, Neyrolles O. Macrophage polarization: convergence point targeted by mycobacterium tuberculosis and HIV. Front Immunol 2011; 2: 43
5. Flynn JL, Chan J, Lin PL. Macrophages and control of granulomatous inflammation in tuberculosis. Mucosal Immunol 2011; 4: 271-278
6. Martinez FO, Gordon S. The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000prime Rep 2014; 6: 13
7. Lugo-Villarino G, Neyrolles O. Manipulation of the mononuclear phagocyte system by Mycobacterium tuberculosis. Cold Spring Harb Perspect Med 2014; 4: a018549
8. O'Garra A, Redford PS, McNab FW, et al. The immune response in tuberculosis. Annu Rev Immunol 2013; 31: 475-527
9. Cambier CJ, Falkow S, Ramakrishnan L. Host evasion and exploitation schemes of Mycobacterium tuberculosis. Cell 2014; 159: 1497-1509
10. Wong KL, Yeap WH, Tai JJ, et al. The three human monocyte subsets: implications for health and disease. Immunol Res 2012; 53: 41-57
11. Robbins CS, Swirski FK. The multiple roles of monocyte subsets in steady state and inflammation. Cell Mol Life Sci 2010; 67: 2685-2693
12. Ziegler-Heitbrock L. The CD14+ CD16+ blood monocytes: their role in infection and inflammation. J Leukoc Biol 2007; 81: 584-592
13. Frankenberger M, Sternsdorf T, Pechumer H, Pforte A, Ziegler-Heitbrock HW. Differential cytokine expression in human blood monocyte subpopulations: a polymerase chain reaction analysis. Blood 1996; 87: 373-377
14. Frankenberger M, Hofer TP, Marei A, et al. Transcript profiling of CD16-positive monocytes reveals a unique molecular fingerprint. Eur J Immunol 2012; 42: 957-974
15. Szaflarska A, Baj-Krzyworzeka M, Siedlar M, et al. Antitumor response of CD14+/CD16+ monocyte subpopulation. Exp Hematol 2004; 32: 748-755
16. Belge KU, Dayyani F, Horelt A, et al. The proinflammatory CD14+CD16+DR++ monocytes are a major source of TNF. J Immunol 2002; 168: 3536-3542
17. Aguilar-Ruiz SR, Torres-Aguilar H, Gonzalez-Dominguez E, et al. Human CD16+ and CD16-monocyte subsets display unique effector properties in inflammatory conditions in vivo. J Leukoc Biol 2011; 90: 1119-1131
18. Balboa L, Romero MM, Basile JI, et al. Paradoxical role of CD16+CCR2+CCR5+ monocytes in tuberculosis: efficient APC in pleural effusion but also mark disease severity in blood. J Leukoc Biol 2011; 90: 69-75
19. Balboa L, Romero MM, Laborde E, et al. Impaired dendritic cell differentiation of CD16-positive monocytes in tuberculosis: role of p38 MAPK. Eur J Immunol 2013; 43: 335-347
20. Tung YC, Ou TT, Tsai WC. Defective Mycobacterium tuberculosis antigen presentation by monocytes from tuberculosis patients. Int J Tuberc Lung Dis 2013; 17: 1229-1234
21. Skold M, Behar SM. Tuberculosis triggers a tissue-dependent program of differentiation and acquisition of effector functions by circulating monocytes. J Immunol 2008; 181: 6349-6360
22. Remoli ME, Giacomini E, Petruccioli E, et al. Bystander inhibition of dendritic cell differentiation by Mycobacterium tuberculosis-induced IL-10. Immunol Cell Biol 2011; 89: 437-446
23. Murray PJ, Allen JE, Biswas SK, et al. Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity 2014; 41: 14-20
24. Calzada-Wack JC, Frankenberger M, Ziegler-Heitbrock HW. Interleukin-10 drives human monocytes to CD16 positive macrophages. J Inflamm 1996; 46: 78-85
25. Zizzo G, Hilliard BA, Monestier M, Cohen PL. Efficient clearance of early apoptotic cells by human macrophages requires M2c polarization and MerTK induction. J Immunol 2012; 189: 3508-3520
26. Sironi M, Martinez FO, D'Ambrosio D, et al. Differential regulation of chemokine production by Fcgamma receptor engagement in human monocytes: association of CCL1 with a distinct form of M2 monocyte activation (M2b, Type 2). J Leukoc Biol 2006; 80: 342-349
27. Jaguin M, Houlbert N, Fardel O, Lecureur V. Polarization profiles of human M-CSF-generated macrophages and comparison of M1-markers in classically activated macrophages from GM-CSF and M-CSF origin. Cell Immunol 2013; 281: 51-61
28. Mantovani A, Sica A, Sozzani S, et al. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 2004; 25: 677-686
29. Verreck FA, de Boer T, Langenberg DM, van der Zanden L, Ottenhoff TH. Phenotypic and functional profiling of human proinflammatory type-1 and anti-inflammatory type-2 macrophages in response to microbial antigens and IFN-gammaand CD40L-mediated costimulation. J Leukoc Biol 2006; 79: 285-293
30. Verreck FA, de Boer T, Langenberg DM, et al. Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria. Proc Natl Acad Sci USA 2004; 101: 4560-4565
31. Olobo JO, Geletu M, Demissie A, et al. Circulating TNF-alpha, TGF-beta, and IL-10 in tuberculosis patients and healthy contacts. Scand J Immunol 2001; 53: 85-91
32. Liang L, Zhao YL, Yue J, et al. Interleukin-10 gene promoter polymorphisms and their protein production in pleural fluid in patients with tuberculosis. FEMS Immunol Med Microbiol 2011; 62: 84-90
33. Roodgar M, Lackner A, Kaushal D, et al. Expression levels of 10 candidate genes in lung tissue of vaccinated and TB-infected cynomolgus macaques. J Med Primatol 2013; 42: 161-164
34. Wang C, Peyron P, Mestre O, et al. Innate immune response to Mycobacterium tuberculosis Beijing and other genotypes. PLoS One 2010; 5: e13594
35. Szanto A, Balint BL, Nagy ZS, et al. STAT6 transcription factor is a facilitator of the nuclear receptor PPARgamma-reg ulated gene expression in macrophages and dendritic cells. Immunity 2010; 33: 699-712
36. Lang R. Tuning of macrophage responses by Stat3-inducing cytokines: molecular mechanisms and consequences in infection. Immunobiology 2005; 210: 63-76
37. Troegeler A, Lastrucci C, Duval C, et al. An efficient siRNA-mediated gene silencing in primary human monocytes, dendritic cells and macrophages. Immunol Cell Biol 2014; 92: 699-708
38. Fabriek BO, Dijkstra CD, van den Berg TK. The macrophage scavenger receptor CD163. Immunobiology 2005; 210: 153-160
39. Zagorska A, Traves PG, Lew ED, Dransfield I, Lemke G. Diversification of TAM receptor tyrosine kinase function. Nat Immunol 2014; 15: 920-928
40. Knudsen TB, Gustafson P, Kronborg G, et al. Predictive value of soluble haemoglobin scavenger receptor CD163 serum levels for survival in verified tuberculosis patients. Clin Microbiol Infect 2005; 11: 730-735
41. Lugo-Villarino G, Hudrisier D, Benard A, Neyrolles O. Emerging trends in the formation and function of tuberculosis granulomas. Front Immunol 2012; 3: 405
42. Mattila JT, Ojo OO, Kepka-Lenhart D, et al. Microenvironments in tuberculous granulomas are delineated by distinct populations of macrophage subsets and expression of nitric oxide synthase and arginase isoforms. J Immunol 2013; 191: 773-784
43. Cambier CJ, Takaki KK, Larson RP, et al. Mycobacteria manipulate macrophage recruitment through coordinated use of membrane lipids. Nature 2014; 505: 218-222
44. Ramakrishnan L. Revisiting the role of the granuloma in tuberculosis. Nat Rev Immunol 2012 12: 352-366
45. Van Goethem E, Poincloux R, Gauffre F, Maridonneau-Parini I, Le Cabec V. Matrix architecture dictates three-dimensional migration modes of human macrophages: differential involvement of proteases and podosome-like structures. J Immunol 2010 184: 1049-1061
46. Cougoule C, Le Cabec V, Poincloux R, et al. Three-dimensional migration of macrophages requires Hck for podosome organization and extracellular matrix proteolysis. Blood 2010; 115: 1444-1452
47. Maridonneau-Parini I. Control of macrophage 3D migration: a therapeutic challenge to limit tissue infiltration. Immunol Rev 2014; 262: 216-231
48. Antonelli LR, Gigliotti Rothfuchs A, Goncalves R, et al. Intranasal Poly-IC treatment exacerbates tuberculosis in mice through the pulmonary recruitment of a pathogen-permissive monocyte/macrophage population. J Clin Invest 2010; 120: 1674-1682
49. Cougoule C, Van Goethem E, Le Cabec V, et al. Blood leukocytes and macrophages of various phenotypes have distinct abilities to form podosomes and to migrate in 3D environments. Eur J Cell Biol 2012; 91: 938-949
50. Yeh HH, Lai WW, Chen HH, Liu HS, Su WC. Autocrine IL-6-induced Stat3 activation contributes to the pathogenesis of lung adenocarcinoma and malignant pleural effusion. Oncogene 2006; 25: 4300-4309
51. Shi C, Pamer EG. Monocyte recruitment during infection and inflammation. Nat Rev Immunol 2011; 11: 762-774
52. Freeman GJ, Long AJ, Iwai Y, et al. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J Exp Med 2000; 192: 1027-1034
53. Lawrence T, Natoli G. Transcriptional regulation of macrophage polarization: enabling diversity with identity. Nat Rev Immunol 2011; 11: 750-761
54. Jamil B, Shahid F, Hasan Z, et al. Interferon gamma/IL10 ratio defines the disease severity in pulmonary and extra pulmonary tuberculosis. Tuberculosis (Edinb) 2007; 87: 279-287
55. Verbon A, Juffermans N, Van Deventer SJ, et al. Serum concentrations of cytokines in patients with active tuberculosis (TB) and after treatment. Clin Exp Immunol 1999; 115: 110-113
56. Bonecini-Almeida MG, Ho JL, Boechat N, et al. Down-modulation of lung immune responses by interleukin-10 and transforming growth factor beta (TGF-beta) and analysis of TGF-beta receptors I and II in active tuberculosis. Infect Immun 2004; 72: 2628-2634
57. Souza-Lemos C, de-Campos SN, Teva A, Porrozzi R, Grimaldi G Jr. In situ characterization of the granulomatous immune response with time in nonhealing lesional skin of Leishmania braziliensis-infected rhesus macaques (Macaca mulatta). Vet Immunol Immunopathol 2011; 142: 147-155
58. Wiesner C, Le-Cabec V, El Azzouzi K, Maridonneau-Parini I, Linder S. Podosomes in space: macrophage migration and matrix degradation in 2D and 3D settings. Cell Adh Migr 2014; 8: 179-191
59. Jevnikar Z, Mirkovic B, Fonovic UP, et al. Three-dimensional invasion of macrophages is mediated by cysteine cathepsins in protrusive podosomes. Eur J Immunol 2012; 42: 3429-3441
60. Van Goethem E, Guiet R, Balor S, et al. Macrophage podosomes go 3D. Eur J Cell Biol 2011; 90: 224-236
61. Guiet R, Van Goethem E, Cougoule C, et al. The process of macrophage migration promotes matrix metalloproteinase-independent invasion by tumor cells. J Immunol 2011; 187: 3806-3814
62. Elkington P, Shiomi T, Breen R, et al. MMP-1 drives immunopathology in human tuberculosis and transgenic mice. J Clin Invest 2011; 121: 1827-1833
63. Rottenberg ME, Carow B. SOCS3 and STAT3, major controllers of the outcome of infection with Mycobacterium tuberculosis. Semin Immunol 2014; 26: 518-532
64. O'Leary S, O'Sullivan MP, Keane J. IL-10 blocks phagosome maturation in mycobacterium tuberculosis-infected human macrophages. Am J Respir Cell Mol Biol 2011; 45: 172-180
65. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001; 19: 683-765
66. Schreiber T, Ehlers S, Heitmann L, et al. Autocrine IL-10 induces hallmarks of alternative activation in macrophages and suppresses antituberculosis effector mechanisms without compromising T cell immunity. J Immunol 2009; 183: 1301-1312
67. Holscher C, Holscher A, Ruckerl D, et al. The IL-27 receptor chain WSX-1 differentially regulates antibacterial immunity and survival during experimental tuberculosis. J Immunol 2005; 174: 3534-3544
68. Carow B, Reuschl AK, Gavier-Widen D, et al. Critical and independent role for SOCS3 in either myeloid or T cells in resistance to Mycobacterium tuberculosis. PLoS Pathog 2013; 9: e1003442
69. Zizzo G, Guerrieri J, Dittman LM, Merri JT, Cohen PL. Circulating levels of soluble MER in lupus reflect M2c activation of monocytes/macrophages, autoantibody specificities and disease activity. Arthritis Res Ther 2013; 15: R212
70. Tang Y, Hua SC, Qin GX, Xu LJ, Jiang YF. Different subsets of macrophages in patients with new onset tuberculous pleural effusion. PLoS One 2014; 9: e88343
71. Cyktor JC, Carruthers B, Kominsky RA, et al. IL-10 inhibits mature fibrotic granuloma formation during Mycobacterium tuberculosis infection. J Immunol 2013; 190: 2778-2790
72. Girgis NM, Gundra UM, Ward LN, et al. Ly6Chigh monocytes become alternatively activated macrophages in schistosome granulomas with help from CD4+ cells. PLoS Pathog 2014; 10: e1004080
73. Graham DK, Dawson TL, Mullaney DL, Snodgrass HR, Earp HS. Cloning and mRNA expression analysis of a novel human protooncogene, c-mer. Cell Growth Differ 1994; 5: 647-657
74. Hayakawa F, Sugimoto K, Harada Y, et al. A novel STAT inhibitor, OPB-31121, has a significant antitumor effect on leukemia with STAT-addictive oncokinases. Blood Cancer J 2013; 3: e166
75. Iwamaru A, Szymanski S, Iwado E, et al. A novel inhibitor of the STAT3 pathway induces apoptosis in malignant glioma cells both in vitro and in vivo. Oncogene 2007; 26: 2435-2444
76. Tobin DM, Roca FJ, Oh SF, et al. Host genotype-specific therapies can optimize the inflammatory response to mycobacterial infections. Cell 2012; 148: 434-446